CCR2 PET Imaging Head and Neck Squamous Cell Carcinoma

NCT07659678 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Head and Neck Squamous Cell Carcinoma
Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)
Head and Neck Squamous Cell Carcinoma HNSCC

Interventions

DRUG: 64Cu-DOTA-ECL1i

Sponsor

Washington University School of Medicine

Collaborators

[object Object]